Author: admin

Nutrix confirmed its attendance to the ATTD (Advanced Treatment & Technologies for Diabetes) international conference that will take place in Madrid, Spain from February 19th to 22nd.

The ATTD is a unique Conference that provides a world-class platform for clinicians and scientists to present, discuss and exchange insights on the most rapidly evolving area of diabetes technology and treatments. ATTD 2020 ( The 13th International Conference on Advanced Technologies & Treatments for Diabetes ) will showcase the latest, world-changing, innovations and research in Technologies & Treatments for Diabetes.

If you are attending the conference and wish to schedule an appointment with Nutrix, please reach out to us by email.

You can find here the full list of sponsors and exhibitors.

Nutrix has been selected by BaselArea.swiss as one of the six participants in the DayOne Accelerator programme, which caters Digital Health startups promoting the health of children and young people.

Out of the six participants, four will receive non-dilutive funding of 50,000 Swiss francs. All the participants will benefit from BaselArea.swiss, which is providing support by connecting them to a network of potential partners and customers, including the particularly distinguished University Children’s Hospital Basel (UKBB).

A total of 120 startups applied to the competition, and 14 were shortlisted. These companies worked in part with UKBB to develop their business ideas, before six were chosen by a panel of experts from the region to progress to the accelerator. One of the participants is the Basel company Nutrix, which is developing a nanosensor for glucose monitoring in saliva to prevent diabetes. 

Further reading:

• full DayOne Accelerator press release
• More on DayOne
• DayOne Accelerator